Logo

    immunotherapies

    Explore " immunotherapies" with insightful episodes like "Best of: Guided missiles target cancer", "Advances in biology & biotech: With Avraneel Part 2", "NK cell-based cancer immunotherapies", "How our immune System Fights Cancer: Knowledge to Help you Navigate the Cancer Maze" and "Navigating the Brain Cancer Maze| Promising Results From World-First Brain Cancer Trials" from podcasts like ""The Future of Everything", "Simblified", "Immuno Oncology Talks", "Navigating the Cancer Maze" and "Navigating the Cancer Maze"" and more!

    Episodes (5)

    Best of: Guided missiles target cancer

    Best of: Guided missiles target cancer

    Almost everyone knows someone who has battled cancer. Today, on The Future of Everything, we’re re-running our episode with Professor Jennifer Cochran who is bringing some hope in this area through work she and her lab are doing to find ways to localize therapies directly to the site of cancer tumors for more efficient and effective treatment. You won’t want to miss this one, it’s full of inspiring insights that will hopefully move us toward a future of improving outcomes for cancer patients.

    Episode Transcripts >>> The Future of Everything Website

    Connect with Russ >>> Threads or Twitter/X

    Connect with School of Engineering >>> Twitter/X

    Chapters:

    (00:00:00) Introduction

    Host Russ Altman introduces the episode, highlighting the widespread impact of cancer and the need for innovative treatment methods.

    (00:00:45) Traditional Cancer Treatments

    Overview of conventional cancer treatments: surgery, radiation, and chemotherapy. Challenges and limitations associated with existing treatments.

    (00:03:30) New Approaches to Cancer Therapy

    Exploration of targeted therapies utilizing biological understanding of cancer cells. 

    (00:05:46) Guided Chemotherapy Missiles

    Introduction of guest Dr. Jennifer Cochran and her work developing ‘guided chemotherapy missiles’. Dr Cochran explains how they work and the benefits of them.

    (00:09:04) Directed Evolution and Designer Proteins

    Introduction to the concept of directed evolution, the process of driving evolution in a test tube to create designer proteins with specific properties.

    (00:11:16) Utilizing Squirting Cucumber Seed Peptides for Chemotherapy

    Dr. Cochran discusses how they transformed a peptide from the seeds of the squirting cucumber into a tumor-targeting agent, the challenges of the process and the current state of the research.

    (00:14:56) Immunotherapy and Cancer Treatment

    Introduction to immunotherapy and how these therapies work in our body to fight cancers

    (00:16:45) Orchestrating Immune Responses: Combining Immunotherapy and Targeted Molecules

    Dr. Cochran explains the collaboration between tumor targeting technology and immunotherapy and current developments.

    (00:20:08) Making Immunotherapy Accessible: Challenges and Innovations

    Dr. Cochran discusses the availability of immunotherapies for cancer patients and the need for broader accessibility.

    (00:21:30) Interdisciplinary Collaboration and Technology Application

    Exploration of interdisciplinary collaborative research, the challenges and opportunities.

    (00:22:59) Translating Lab Discoveries into Treatments

    Russ & Jennifer discuss the process and challenges of translating lab research from academia into actual drug development including “ the valley of death”

    Connect With Us:

    Episode Transcripts >>> The Future of Everything Website

    Connect with Russ >>> Threads or Twitter/X

    Connect with School of Engineering >>> Twitter/X

    Advances in biology & biotech: With Avraneel Part 2

    Advances in biology & biotech: With Avraneel Part 2

    We speak to Simblified fan (!) and microbiologist Avraneel Paul on a whole bunch of things related to what happens inside our body! Viruses and bacteria, how vaccines work, how those WBC badasses keep us safe, and so on. Along the way, we also speak about exciting advancements like CRISPR, and explore philosophical questions like whether Covid has changed the field... And what a day in the life of a scientist looks like. There's loads of trivia, loads of simblification and a few bad jokes as well in this two-part episode. We hope you like it and have renewed appreciation for scientists (and your body!) after it!

    Add one part news, one part bad jokes, one part Wikipedia research, one part cult references from spending too much time on the internet, one part Wodehouse quotes, and one part quality puns, and you get Simblified.

    A weekly podcast to help you appear smarter, to an audience that knows no less! Your four hosts - Chuck, Naren, Srikeit, and Tony attempt to deconstruct topics with humor (conditions apply). Fans of the show have described it as "fun conversations with relatable folks", "irreverent humor", "the funniest thing to come out of Malad West" and "if I give you a good review will you please let me go".

    Started in 2016 as a creative outlet, Simblified now has over 300 episodes, including some live ones, and some with guests who are much smarter than the hosts. Welcome to the world of Simblified!

    You can contact the hosts on:

    Chuck: http://twitter.com/chuck_gopal  / http://instagram.com/chuckofalltrades

    Naren: http://twitter.com/shenoyn  / http://instagram.com/shenoynv

    Tony: http://twitter.com/notytony  / http://instagram.com/notytony

    Srikeit: http://twitter.com/srikeit  / http://instagram.com/srikeit

    See omnystudio.com/listener for privacy information.

    NK cell-based cancer immunotherapies

    NK cell-based cancer immunotherapies

    In our second episode of the “Immuno Oncology Talks”, Associate Professor Evren Alici, from the Karolinska Institutet in Sweden, was invited to discuss NK cell-based cancer immunotherapies, accompanied by his colleague Professor Hans-Gustaf Ljunggren. The primary focus of Professor Alici´s research is on novel NK cell-based therapies, and includes generation and testing of genetically engineered NK cells, like chimeric receptor and CAR-NK cells. Associate Professor Alici is also co-director of the NextGenNK Competence Center (https://ki.se/en/research/nextgennk).

    For more information please visit:
    Sanofi Immuno Oncology Talks website

    MAT-BE-2200747 (ver 1.0) 09 2022

    How our immune System Fights Cancer: Knowledge to Help you Navigate the Cancer Maze

    How our immune System Fights Cancer: Knowledge to Help you Navigate the Cancer Maze
    My guest on Navigating the cancer Maze this week is Prof Dr. Jérôme Galon, Research Director at INSERM (National Institute of Health and Medical Research) & leader of the INSERM Integrative Cancer Immunology laboratory, at the Cordeliers Research Centre. His current interests & major contributions concern basic & translational research in cancer immunology, using systems biology. His laboratory has made some ground-breaking findings demonstrating that the adaptive immune response within a tumor was a better predictor of survival than traditional staging based on the size and spread of a tumor.The new wave of immunotherapies reflects what has been known for some time; that the answer to cancer is in you! But it is not that simple. Our immune system is complex and intricate & as science unravels its mysteries, we are developing new understandings of how the immune system can be captured & recruited in the laboratory; retrained and returned to you the patient! www.gracegawlermedia.com

    Navigating the Brain Cancer Maze| Promising Results From World-First Brain Cancer Trials

    Navigating the Brain Cancer Maze| Promising Results From World-First Brain Cancer Trials
    Today I will be interviewing Professor Rajiv Khanna a leading researcher at The QIMR Berghofer Medical Research Institute, Brisbane, Australia; a world progressive translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Professor Khanna has been researching immunotherapies & has had a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body. When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy - manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said. Be informed about the answer to cancer. Support Immunotherapy week. More info www.qimrberghofer.edu.au & gracegawlermedia.com
    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io